SCHEMBL1534597

SCHEMBL1534597

Cn1ccc2c(=O)c(I)c(-c3ccccc3)oc2c1=O

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ABCG2 Q9UNQ0 3/20 0.39
ABCC1 P33527 1/20 0.39
KDM4E B2RXH2 7/20 0.38
ALDH1A1 P00352 4/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
CYP1B1 Q16678 4/20 0.37
CYP1A2 P05177 4/20 0.37
CYP1A1 P04798 3/20 0.37
CYP3A4 P08684 4/20 0.36
CYP2D6 P10635 3/20 0.36
MAPT P10636 3/20 0.36
HPGD P15428 2/20 0.36
TSHR P16473 2/20 0.36
MAPK1 P28482 2/20 0.36
CYP2C19 P33261 2/20 0.36
HSD17B10 Q99714 2/20 0.36
CYP2C9 P11712 1/20 0.36
DDR2 Q16832 1/20 0.36
BRD4 O60885 1/20 0.36
ABCB1 P08183 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1534503 0.81 ALDH1A1 (0.39) ABCG2ABCC1KDM4EALDH1A1SMN1; SMN2
SCHEMBL1534443 0.81 ABCG2 (0.37) ABCG2ABCC1KDM4EALDH1A1SMN1; SMN2
SCHEMBL1534677 0.78 ABCG2 (0.35) ABCG2ABCC1KDM4EALDH1A1CYP1B1
SCHEMBL1534783 0.76 ABCG2 (0.38) ABCG2ABCC1KDM4EALDH1A1SMN1; SMN2
SCHEMBL1534899 0.75 DPP4 (0.41) ABCG2ABCC1KDM4EALDH1A1CYP1B1
SCHEMBL1534587 0.75 ABCG2 (0.42) ABCG2ABCC1KDM4EALDH1A1SMN1; SMN2
SCHEMBL1534426 0.72 ABCG2 (0.43) ABCG2ABCC1KDM4EALDH1A1SMN1; SMN2
SCHEMBL1534523 0.72 ABCG2 (0.43) ABCG2ABCC1KDM4EALDH1A1SMN1; SMN2
SCHEMBL1534501 0.72 MAOA (0.57) ABCG2ABCC1KDM4EALDH1A1SMN1; SMN2
SCHEMBL12274080 0.72 AKT1 (0.44)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8546376-B2 Pharmaceutical compounds ALMAC DISCOVERY LIMITED (GB) 2013-10-01 US disclosed
US-20120238541-A1 PHARMACEUTICAL COMPOUNDS ALMAC DISCOVERY LIMITED (GB) 2012-09-20 US disclosed
EP-2473495-A1 PHARMACEUTICAL COMPOUNDS Almac Discovery Limited (GB) 2012-07-11 EP disclosed
WO-2011033265-A1 PHARMACEUTICAL COMPOUNDS ALMAC DISCOVERY LIMITED (GB) 2011-03-24 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120238541-A1 PHARMACEUTICAL COMPOUNDS PIK3CA, PLK1, MTOR ABCG2 507/4885ABCC1 1213/4885KDM4E 1952/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.